Haemovigilance in Czech Republic

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F27283933%3A_____%2F17%3A00005436" target="_blank" >RIV/27283933:_____/17:00005436 - isvavai.cz</a>

Výsledek na webu

—

DOI - Digital Object Identifier

—

Jazyk výsledku

angličtina

Název v původním jazyce

Haemovigilance in Czech Republic

Popis výsledku v původním jazyce

Haemovigilance is a system of processes, comprissing detection, summary and analysis of information concerning severe adverse effects and events on the part of transfusion donors and recipients and epidemiological monitoring of blood donors, The wider definition of haemovigilance includes clinical section, which means transfusion indication criteria, their control and good practise in the course of transfusion administration. A system of reporting of adverse effects of transfusion is of key importance. Thelegislative standard for the European Union member states is Directive No.2002/98/EC, which provides quality and safety standards for production of blood components, it does not solve the clinical section of problems. The basic recommendations for clinical practice can be found in the Guide to the Preparation, Use and Quality Assurance of Blood Components. The detailed instructions in guidelines of British Society for Hemstology and the recommendations for haemovigilance in ISBT standards. In the Czech Republic, the field of production of blood products is handled by the Medicine Act and Degree of Blood. These legal standards alsso scontain basic provision for haemovigilance especially for traceability of blood components and producing reports of serious transfusion reactions and events. The main institution is the State INstitute for Drug Control(SIDC), which issues a manufacturing authorization for transfusion services and the Ministry of Health. The Society for Transfusion Medicine has issued professional standards for key areas of transfusion service including national standard for the administration of blood components. In CR serious transfusion reactions and events are reported to SIDC. All reactions are reported to blood banks in hospitals. Medical faculties have begun pregraduate education in transfusiology and the textbooks od transfusion medicine have been published, However, the situation is not optimal. Most significantly national guidelines for the use blood components are missing.

Název v anglickém jazyce

Haemovigilance in Czech Republic

Popis výsledku anglicky

Haemovigilance is a system of processes, comprissing detection, summary and analysis of information concerning severe adverse effects and events on the part of transfusion donors and recipients and epidemiological monitoring of blood donors, The wider definition of haemovigilance includes clinical section, which means transfusion indication criteria, their control and good practise in the course of transfusion administration. A system of reporting of adverse effects of transfusion is of key importance. Thelegislative standard for the European Union member states is Directive No.2002/98/EC, which provides quality and safety standards for production of blood components, it does not solve the clinical section of problems. The basic recommendations for clinical practice can be found in the Guide to the Preparation, Use and Quality Assurance of Blood Components. The detailed instructions in guidelines of British Society for Hemstology and the recommendations for haemovigilance in ISBT standards. In the Czech Republic, the field of production of blood products is handled by the Medicine Act and Degree of Blood. These legal standards alsso scontain basic provision for haemovigilance especially for traceability of blood components and producing reports of serious transfusion reactions and events. The main institution is the State INstitute for Drug Control(SIDC), which issues a manufacturing authorization for transfusion services and the Ministry of Health. The Society for Transfusion Medicine has issued professional standards for key areas of transfusion service including national standard for the administration of blood components. In CR serious transfusion reactions and events are reported to SIDC. All reactions are reported to blood banks in hospitals. Medical faculties have begun pregraduate education in transfusiology and the textbooks od transfusion medicine have been published, However, the situation is not optimal. Most significantly national guidelines for the use blood components are missing.

Druh

O - Ostatní výsledky

CEP obor

—

OECD FORD obor

30230 - Other clinical medicine subjects

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2017

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů